Key Sleeping Bruxism Treatment Market Players:
- Randmark Dental Products, LLC.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Ivoclar Vivadent AG
- Ipsen S.A.
- Merz Pharma GmbH & Co. KGaA
- Carestream Dental
- Akervall Technologies Inc
- Planmeca Oy
- S4S Limited
- Patterson Dental Supply, Inc
- Henry Schein, Inc
- Pfizer, Inc
- GC International AG
- ALIGNERCO
Key companies in the sleeping bruxism treatment market are innovating by developing advanced solutions like custom-made mouthguards, biofeedback devices, and wearable technologies. These innovations enable more effective management by offering personalized treatments, real-time monitoring, and non-invasive options. Companies are also enhancing diagnostic tools, such as portable sleep monitors, to facilitate early detection, driving growth by improving treatment outcomes and patient adherence. These companies are:
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of sleeping bruxism treatment is estimated at USD 583.05 million.
Sleeping Bruxism Treatment Market size was over USD 559.87 million in 2025 and is poised to exceed USD 877.82 million by 2035, growing at over 4.6% CAGR during the forecast period i.e., between 2026-2035.
North America dominates the Sleeping Bruxism Treatment Market with a 39.5% share, driven by rising bruxism cases, stress awareness, and innovations in diagnostic and non-invasive treatment options, ensuring leadership through 2026–2035.
Key players in the market include Carestream Dental, Akervall Technologies Inc., Planmeca Oy.
